Transport associated protein splice variants
AssigneeThe General Hospital Corporation
InventorDenise L. Faustman
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe General Hospital Corporation
InventorDenise L. Faustman
Estimating the term…
Splice variants of known TAP1 and TAP2 proteins, which are involved in translocation of antigen peptides into the endoplasmic reticulum for complexing with MHC class I molecules and eventual display on the cell surface, are disclosed. A fully sequenced and characterized splice variant of TAP2, designated TAP2iso, is shown to form functional heterodimers with TAP1 and to exhibit a peptide specificity that differs from previously studied TAP1/TAP2 transporter proteins. The discovery of splice variant TAP subunits alters the prior theory of immune response and introduces a mechanism for diversification of antigen display to the CD8-positive T cells of the immune system. Methods for diagnosis and treatment of diseases or conditions associated with abnormal TAP splice variant expression, or of expanding the reptertoire of antigen peptides to which an individual's immune system is capable of responding, are also disclosed.
An isolated nucleic acid comprising a polynucleotide sequence that encodes a TAP2 splice variant having the amino acid sequence of SEQ ID NO:
An isolated nucleic acid encoding a TAP2 exon 12 polypeptide.
Dependencies are inferred from the claim text.